Evaluation of the PACE 2 Neisseria gonorrhoeae assay by three public health laboratories.
AUTOR(ES)
Hale, Y M
RESUMO
The Gen-Probe PACE 2 DNA probe assay for Neisseria gonorrhoeae was compared with conventional culture techniques in three Florida public health laboratories with 436 patients (271 females and 165 males). The prevalence rates based on culture were 19.9, 55.8, and 33.5% for females, for males, and overall, respectively. Twenty-seven probe-positive specimens gave negative culture results. Twenty of these specimens were resolved as true positives after retesting with a probe competition assay. The resolved sensitivity, specificity, positive predictive value, and negative predictive value were 99.4, 99.6, 99.4, and 99.6%, respectively.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=262787Documentos Relacionados
- Evaluation of five gentamicin assay procedures for clinical microbiology laboratories.
- Evaluation of culture and the Gen-Probe PACE 2 assay for detection of Neisseria gonorrhoeae and Chlamydia trachomatis in endocervical specimens transported to a state health laboratory.
- U.S. hospital mycobacteriology laboratories: status and comparison with state public health department laboratories.
- Evaluation of four gentamicin and tobramycin assay procedures for clinical laboratories.
- Current practices in mycobacteriology: results of a survey of state public health laboratories.
